Today's brief — CIO Daily Brief: signal-ranked tech news, podcasts & intelligence for CIOs and IT leaders

Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck

Stanford's Virtual Biotech demonstrates that orchestrating tens of thousands of specialized AI agents outperforms single monolithic models for complex problem-solving, with practical validation when Merck independently confirmed one of the system's drug designs. The key technical innovation—Paperclip, an AI-native virtual file system that interfaces legacy databases—solves the orchestration bottleneck that will constrain enterprise multi-agent deployments at scale. For IT leaders, this signals a fundamental shift from single-agent automation to distributed agent ecosystems, requiring new architectural approaches to data integration and legacy system modernization.